HPV Roundtable: Creating a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus Vaccination- Financed in Part by 2016 Prevention and Public Health Funds

Funding Opportunity Number: CDC-RFA-IP16-1602PPHF16
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
CFDA Number: 93.268
Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Agency Name: HHS-CDC-NCIRD
Closing Date: May 30, 2016
Award Ceiling: $500,000
Expected Number of Awards: 1
Creation Date: Mar 29, 2016
Funding Opportunity Description: The purpose of this cooperative agreement is to develop and administer a national network of cancer prevention organizations to promote, in coordination with immunization stakeholders, efforts and activities to improve HPV vaccination delivery for the prevention of HPV-related cancers. This network will include cancer prevention stakeholders with channels to provide education, outreach, and training to the public and providers. Through engagement and coordination with existing immunization stakeholders, this network will work to increase public and provider understanding of the burden of HPV-associated cancers that can be prevented by HPV vaccination and accelerate the full implementation of HPV vaccination so as to further the prevention of HPV-associated cancers. 1. Develop and maintain a national network comprised of cancer-prevention organizations that have the capacity to engage clinical and immunization partners at national, regional, state, tribal, territorial, jurisdictional and local level and actively participate in coordinated efforts to promote HPV vaccination as a strategyfor cancer prevention. 2. Convene a national meeting of cancer prevention and HPV immunization stakeholders to identify strategies to decrease missed opportunities by providers to recommend and administer HPV vaccine and increase parents’ and adolescents’ acceptance of HPV vaccination. 3. Fund and manage several small projects (maximum of 7) or a few large pilot projects (e.g. 1-3) identified by network stakeholders as high priorities for addressing barriers to HPV vaccine uptake.

Source:: http://www.grants.gov/web/grants/view-opportunity.html?oppId=282611


Please enter your comment!
Please enter your name here